[15] Another two interesting studies are reported in the review by Flora et al. [71] The first study was performed in 2637 patients with chronic liver disease, treated with high doses of silymarin ...

The flavonoid silymarin and one of its structural components, silibinin, are substances with documented hepatoprotective properties. Their mechanisms of action are still poorly understood.